Company intelligence / Profile preview
Duopharma Biotech
- Ownership
- Private
- Development stage
- Other
Overview
Duopharma Biotech manufactures and markets over 300 generic drugs and specialty pharmaceuticals. It has achieved key milestones such as installing Malaysia’s first biological pre-filled syringe line for an erythropoietin biosimilar. The company supplies both domestic and international markets with a diverse product portfolio that includes generics, OTC products, APIs, contract manufacturing services, and some specialty biologics[4][5].
- Therapeutic areas
- Infectious DiseasesEndocrinologyOncologyOtherNephrologyCardiovascular
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Duopharma Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Duopharma Biotech.